304 related articles for article (PubMed ID: 26553164)
1. Coenzyme Q10 for Patients with Parkinson's Disease: A Systematic Review and Meta-Analysis.
Negida A; Menshawy A; El Ashal G; Elfouly Y; Hani Y; Hegazy Y; El Ghonimy S; Fouda S; Rashad Y
CNS Neurol Disord Drug Targets; 2016; 15(1):45-53. PubMed ID: 26553164
[TBL] [Abstract][Full Text] [Related]
2. Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease.
Attia ; Ahmed H; Gadelkarim M; Morsi M; Awad K; Elnenny M; Ghanem E; El-Jaafary S; Negida A
CNS Neurol Disord Drug Targets; 2017; 16(2):169-175. PubMed ID: 27823574
[TBL] [Abstract][Full Text] [Related]
3. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.
; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K
JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227
[TBL] [Abstract][Full Text] [Related]
4. The efficacy and safety of coenzyme Q10 in Parkinson's disease: a meta-analysis of randomized controlled trials.
Zhu ZG; Sun MX; Zhang WL; Wang WW; Jin YM; Xie CL
Neurol Sci; 2017 Feb; 38(2):215-224. PubMed ID: 27830343
[TBL] [Abstract][Full Text] [Related]
5. Coenzyme Q10 for Parkinson's disease.
Liu J; Wang L; Zhan SY; Xia Y
Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
[TBL] [Abstract][Full Text] [Related]
6. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease.
Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N
Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881
[TBL] [Abstract][Full Text] [Related]
7. Effects of coenzyme Q10 supplementation on inflammation, angiogenesis, and oxidative stress in breast cancer patients: a systematic review and meta-analysis of randomized controlled- trials.
Alimohammadi M; Rahimi A; Faramarzi F; Golpour M; Jafari-Shakib R; Alizadeh-Navaei R; Rafiei A
Inflammopharmacology; 2021 Jun; 29(3):579-593. PubMed ID: 34008150
[TBL] [Abstract][Full Text] [Related]
8. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
Liu J; Wang LN; Zhan SY; Xia Y
Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
[TBL] [Abstract][Full Text] [Related]
9. Does high-dose coenzyme Q10 improve oxidative damage and clinical outcomes in Parkinson's disease?
Seet RC; Lim EC; Tan JJ; Quek AM; Chow AW; Chong WL; Ng MP; Ong CN; Halliwell B
Antioxid Redox Signal; 2014 Jul; 21(2):211-7. PubMed ID: 24410614
[TBL] [Abstract][Full Text] [Related]
10. The effects of coenzyme Q10 supplementation on biomarkers of inflammation and oxidative stress in among coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
Jorat MV; Tabrizi R; Kolahdooz F; Akbari M; Salami M; Heydari ST; Asemi Z
Inflammopharmacology; 2019 Apr; 27(2):233-248. PubMed ID: 30758695
[TBL] [Abstract][Full Text] [Related]
11. Can coenzyme Q10 supplementation effectively reduce human tumor necrosis factor-α and interleukin-6 levels in chronic inflammatory diseases? A systematic review and meta-analysis of randomized controlled trials.
Farsi F; Heshmati J; Keshtkar A; Irandoost P; Alamdari NM; Akbari A; Janani L; Morshedzadeh N; Vafa M
Pharmacol Res; 2019 Oct; 148():104290. PubMed ID: 31185284
[TBL] [Abstract][Full Text] [Related]
12. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J; Kompoliti K; Perlmutter JS; Reich S; Stern M; Watts RL; Kurlan R; Molho E; Harrison M; Lew M;
Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness and safety of acupuncture combined with Madopar for Parkinson's disease: a systematic review with meta-analysis.
Liu H; Chen L; Zhang Z; Geng G; Chen W; Dong H; Chen L; Zhan S; Li T
Acupunct Med; 2017 Dec; 35(6):404-412. PubMed ID: 29180347
[TBL] [Abstract][Full Text] [Related]
14. The effects of coenzyme Q10 supplementation on lipid profiles among patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials.
Jorat MV; Tabrizi R; Mirhosseini N; Lankarani KB; Akbari M; Heydari ST; Mottaghi R; Asemi Z
Lipids Health Dis; 2018 Oct; 17(1):230. PubMed ID: 30296936
[TBL] [Abstract][Full Text] [Related]
15. The Effects of Coenzyme Q10 Supplementation on Metabolic Profiles of Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Bakhshayeshkaram M; Lankarani KB; Mirhosseini N; Tabrizi R; Akbari M; Dabbaghmanesh MH; Asemi Z
Curr Pharm Des; 2018; 24(31):3710-3723. PubMed ID: 30417782
[TBL] [Abstract][Full Text] [Related]
16. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
17. Chinese medicine for idiopathic Parkinson's disease: A meta analysis of randomized controlled trials.
Wei W; Chen HY; Fan W; Ye SF; Xu YH; Cai J
Chin J Integr Med; 2017 Jan; 23(1):55-61. PubMed ID: 27796824
[TBL] [Abstract][Full Text] [Related]
18. Measuring disease progression in early Parkinson disease: the National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
Parashos SA; Luo S; Biglan KM; Bodis-Wollner I; He B; Liang GS; Ross GW; Tilley BC; Shulman LM;
JAMA Neurol; 2014 Jun; 71(6):710-6. PubMed ID: 24711047
[TBL] [Abstract][Full Text] [Related]
19. Diabetes, Age, and Duration of Supplementation Subgroup Analysis for the Effect of Coenzyme Q10 on Oxidative Stress: A Systematic Review and Meta-Analysis.
Hajiluian G; Heshmati J; Jafari Karegar S; Sepidarkish M; Shokri A; Shidfar F
Complement Med Res; 2021; 28(6):557-570. PubMed ID: 33866314
[TBL] [Abstract][Full Text] [Related]
20. H. pylori and Parkinson's disease: Meta-analyses including clinical severity.
Dardiotis E; Tsouris Z; Mentis AA; Siokas V; Michalopoulou A; Sokratous M; Dastamani M; Bogdanos DP; Deretzi G; Kountouras J
Clin Neurol Neurosurg; 2018 Dec; 175():16-24. PubMed ID: 30308319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
